Insurances.net
insurances.net » Finance » Aarkstore Enterprise Gastrointestinal Stromal Tumors (gist) Clinical Trials Review, Q4 2010
Finance Investing Loans Personal-Finance Taxes Loan quotes
]

Aarkstore Enterprise Gastrointestinal Stromal Tumors (gist) Clinical Trials Review, Q4 2010

Aarkstore announce a new report "Gastrointestinal Stromal Tumors (GIST) Clinical Trials Review

, Q4 2010 " through its vast collection of market research report.

Summary

Gastrointestinal Stromal Tumors (GIST) Global Clinical Trials Review, Q4, 2010 provides data on the Gastrointestinal Stromal Tumors (GIST) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Gastrointestinal Stromal Tumors (GIST). It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Gastrointestinal Stromal Tumors (GIST)).

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status and trial success rate

- Review of key discontinued trials (suspended, withdrawn and terminated)

- Overview of the enrollment pattern by phase for the past decade

- Number of clinical trials segmented by key drugs

- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.

- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

- Understand the dynamics of a particular indication as a whole

- Examine the performance of the trials in terms of their status, recruitment, success rates and others

- Obtain discontinued trial information for trials across the globe

- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

For more information, please visit:

http://www.aarkstore.com/reports/Gastrointestinal-Stromal-Tumors-GIST-Clinical-Trials-Review-Q4-2010-77111.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise
Money Making Cycle Hp Photosmart Estation C510 Review Dell Xps 15 Review Review : Assassin's Creed 2 Asus Dr 950 Review Riffmaster Pro Review Asus Eee Pc 1015pn Complete Review TruthAboutAbs Secrets Review - An Order You Can't Go Wrong With! Magnetic Sponsoring Review – Does It Work And Is It Worth Purchasing? ZamZuu Review How To Create A Flyer Without Blowing Your Budget Kirby Vacuum Parts Are A Symbol Of Durability And Trust! Make Money From Some Little Known Solutions To Find Diaper Coupons
Write post print
www.insurances.net guest:  register | login | search IP(18.225.92.116) Ljubljana / Ljubljana Processed in 0.008660 second(s), 5 queries , Gzip enabled debug code: 40 , 2668, 385,
Aarkstore Enterprise Gastrointestinal Stromal Tumors (gist) Clinical Trials Review, Q4 2010 Ljubljana